A science-driven, virtual reality solution for personalized aphasia rehabilitation after stroke.

SPARCS enables multi-patient, home-based therapy using immersive VR and explainable AI.

What is SPARCS?

SPARCS stands for Science-based, Personalized Aphasia Rehabilitation Continuum after Stroke.
It brings together neuroscience, clinical expertise, and scalable digital technology to revolutionize the way aphasia is treated.

Why Aphasia?

Aphasia affects around 20% of stroke survivors. It impairs the ability to find and express words, despite intact understanding and motor speech.
Traditional therapies are often costly, isolated, and hard to access—SPARCS changes that.

81M

People live with effects of stroke

20%

of them
suffer from aphasia

Traditional

treatments are costly, passive, and difficult to scale

SPARCS

offers an interactive, active, and science-grounded alternative

VR-based multi-user communication games

Patients collaborate remotely in real time via VR headsets in engaging language tasks.

Explainable AI (XAI)

Perzonalized models adapt theraphy intensity and predict outcomes, supporting clinical decisions.

Professional Dashboard

Clinicians can monitor, analyze, and adjust theraphy remotely through a secure web

Spain – Coordinator

Inovative SME in neurorehabilitation, VR and telerehab solutions

Netherlands – Partner

Experts in Explainable AI & Bayesian modeling for medical applications

Switzerland – Partner

Clinical validation, ethics, and co-development with leading neurorehab teams

Jun 2025

Project Kickoff

Nov 2025

User requirements & architecture defined

May 2026

Multiplayer VR prototype & initial integration

Nov 2026

Clinical protocol, dashboard & pilot ready

Nov 2027

Final validation & commercial readiness

Calle de Venezuela 35, Barcelona, Spain

info@eodynesystems.com

www.eodyne.com

This project (Eurostars‑3 project E! 7829 — “SPARCS”) has received funding from the Eurostars‑3 programme (a Eureka initiative within the European Partnership on Innovative  SMEs), co‑funded by the European Union’s Horizon Europe research and innovation programme.